How Much Upside is Left in Harmony Biosciences (HRMY)? Wall …

6 hours ago · Shares of Harmony Biosciences Holdings, Inc. (HRMY) have gained 8.3% over the past four weeks to close the last trading session at $36.42, but there could still be a solid …

3%
OFF

How Much Upside Is Left In Harmony Biosciences (HRMY)? Wall …

2 weeks from now

6 hours ago · Shares of Harmony Biosciences Holdings, Inc. (HRMY) have gained 8.3% over the past four weeks to close the last trading session at $36.42, but there could still be a solid …

yahoo.com

2%
OFF

Wall Street Analysts Believe Harmony Biosciences Holdings, Inc

2 weeks from now

Jan 23, 2024 · Harmony Biosciences Holdings, Inc. (HRMY) closed the last trading session at $32.53, gaining 1.2% over the past four weeks, but there could be plenty of upside left in the …

nasdaq.com

8%
OFF

Wall Street Analysts Believe Harmony Biosciences Holdings, Inc.

2 weeks from now

Jan 23, 2024 · The mean of analysts' price targets for Harmony Biosciences Holdings, Inc. (HRMY) points to a 28.8% upside in the stock. While this highly sought-after metric has not …

yahoo.com

7%
OFF

How Much Upside Is Left In Harmony Biosciences Holdings, Inc

2 weeks from now

Nov 13, 2023 · Shares of Harmony Biosciences Holdings, Inc. (HRMY) have gained 12.7% over the past four weeks to close the last trading session at $23.78, but there could still be a solid …

nasdaq.com

77%
OFF

HRMY - Harmony Biosciences Holdings Inc Stock Price And Quote

2 weeks from now

Wall Street Analysts Believe Harmony Biosciences Holdings, Inc. (HRMY) Could Rally 28.77%: Here's is How to Trade (Zacks) 04:16AM 18 High Growth Low PE Stocks (Insider Monkey) …

finviz.com

2%
OFF

Wall Street Analysts Believe Harmony Biosciences Holdings, Inc.

2 weeks from now

Jan 23, 2024 · Harmony Biosciences Holdings, Inc. (HRMY) closed the last trading session at $32.53, gaining 1.2% over the past four weeks, but there could be plenty of upside left in the …

tradingview.com

$28.14
OFF

JPMorgan Chase & Co. Purchases 93,622 Shares Of Harmony …

2 weeks from now

1 day ago · Harmony Biosciences Holdings, Inc. has a 1 year low of $28.14 and a 1 year high of $41.61. The stock has a market capitalization of $2.08 billion, a price-to-earnings ratio of …

marketbeat.com

8%
OFF

Wall Street Analysts Believe Harmony Biosciences Holdings, Inc.

2 weeks from now

Jan 23, 2024 · The mean of analysts' price targets for Harmony Biosciences Holdings, Inc. (HRMY) points to a 28.8% upside in the stock. While this highly sought-after metric has not …

zacks.com

$56.00
OFF

Harmony Biosciences Holdings Inc Stock Forecast ... - WallStreetZen

2 weeks from now

On average, Wall Street analysts predict. that Harmony Biosciences Holdings's share price could reach $56.00 by Dec 17, 2025. The average Harmony Biosciences Holdings stock price …

wallstreetzen.com

$201
OFF

Harmony Biosciences Reports Strong 2024 Revenues

2 weeks from now

2 days ago · Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced strong preliminary, unaudited net product revenues for Q4 and full year 2024 of $201 million and …

morningstar.com

6%
OFF

How Much Upside Is Left In Harmony Biosciences Holdings, Inc.

2 weeks from now

Nov 13, 2023 · The mean of analysts' price targets for Harmony Biosciences Holdings, Inc. (HRMY) points to a 76.6% upside in the stock. While this highly sought-after metric has not …

yahoo.com

38%
OFF

Wall Street Analysts Predict A 44.38% Upside In Harmony …

2 weeks from now

Nov 29, 2023 · The average of price targets set by Wall Street analysts indicates a potential upside of 44.4% in Harmony Biosciences Holdings, Inc. (HRMY). While the effectiveness of …

yahoo.com

0%
OFF

Principal Financial Group Inc. Cuts Stock Position In Harmony ...

2 weeks from now

Jan 2, 2025 · Harmony Biosciences's revenue for the quarter was up 16.0% on a year-over-year basis. During the same period last year, the company earned $0.63 EPS. As a group, equities …

marketbeat.com

$12700000
OFF

9020 Wall St, North Bergen, NJ 07047 | NJPropertyRecords

2 weeks from now

9020 WALL ST, NORTH BERGEN, NJ 07047 is a 0 sqft home sold on 08/31/2007 for $12,700,000 and is owned by Skylineview Equities Llc The annual taxes is $321,728.62. The …

njpropertyrecords.com

$8.00
OFF

Cytek Biosciences (NASDAQ:CTKB) Shares Gap Down - MarketBeat

2 weeks from now

4 hours ago · Wall Street Analyst Weigh In. Separately, Piper Sandler upped their target price on Cytek Biosciences from $8.00 to $8.50 and gave the company an "overweight" rating in a …

marketbeat.com

05%
OFF

Can Harmony Biosciences (HRMY) Climb 25.05% To Reach The …

2 weeks from now

Aug 14, 2024 · Harmony Biosciences Holdings, Inc. ... 1.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts …

yahoo.com

38%
OFF

Wall Street Analysts Predict A 44.38% Upside In Harmony …

2 weeks from now

Nov 29, 2023 · Shares of Harmony Biosciences Holdings, Inc. (HRMY) have gained 23.6% over the past four weeks to close the last trading session at $29.09, but there could still be a solid …

nasdaq.com

FAQs about How Much Upside is Left in Harmony Biosciences (HRMY)? Wall … Coupon?

Is Harmony Biosciences (hrmy) a good stock to buy?

Your Privacy Choices Ad Terms Feedback The mean of analysts' price targets for Harmony Biosciences (HRMY) points to a 39.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock. ...

How much upside is left in Harmony Biosciences holdings (hrmy)?

How Much Upside is Left in Harmony Biosciences Holdings, Inc. (HRMY)? Wall Street Analysts Think 76.62% ...

Who is Harmony Biosciences?

HARMONY BIOSCIENCES TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC. Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders. ...

How will FDA approvals affect Wakix's balance sheet?

This recent approval positions the company to meet the demand of more than 20,000 patients in the United States alone. The recent FDA approvals have already started to show a positive impact on its balance sheet. The fiscal second quarter of 2024 resulted in WAKIX Net Revenue growing 29% year-over-year to $172.8 million. ...